跳至主要内容
临床试验/NL-OMON35830
NL-OMON35830已完成2 期

A phase II validation of in vivo Raman spectroscopy for bladder cancer diagnosis - Raman Spectroscopy in Bladder Cancer Diagnosis

niversitair Medisch Centrum Utrecht0 个研究点目标入组 285 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
285

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Subjects (at least 18 years old and mentally competent) that present with bladder cancer symptoms at the outpatient clinic and are scheduled for transurethral resection of tumor or biopsy (TURTB) are candidates for recrution

排除标准

  • Subjects scheduled for TURBT that present with macroscopic hematuria at the time of procedure are excluded from the study as the excess of blood in urine complicates the cystoscopic guidance to sites and affects the Raman spectra.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验